GlaxoSmithKline plcGSK came up with two important announcements related to its respiratory drugs, Nucala and Relvar Breo Ellipta. Nucala a Step Closer to European Approval Glaxo announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use
Glaxo's Eosinophilic Asthma Drug Nucala Wins CHMP Backing
